A Novel Development of Sarcoidosis Following COVID-19 Vaccination and a Literature Review
Sign Up to like & getrecommendations! Published in 2022 at "Internal Medicine"
DOI: 10.2169/internalmedicine.0104-22
Abstract: BNT162b2 (Pfizer/BioNTech) is a coronavirus disease 2019 (COVID-19) vaccine containing nucleoside-modified messenger RNA encoding the severe acute respiratory syndrome coronavirus 2 spike glycoprotein. Recently, ocular complications of mRNA vaccines have been reported increasingly frequently. However,… read more here.
Keywords: novel development; following covid; development sarcoidosis; covid vaccination ... See more keywords